Meenakshi Srinivasan

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Mycobacterium Tuberculosis

General Practice

Top Venues

Clinical and translational science

Gates open research

This page only lists publications with an associated author ORCID identifier.

Publications

Aline Barth, Caroline R Perry, Shaila Shabbir, Maciej J Zamek-Gliszczynski, Sebin Thomas, Etienne F Dumont, Darin B Brimhall, Dung Nguyen, Meenakshi Srinivasan, Brandon Swift
Clinical Assessment of Gepotidacin (GSK2140944) as a Victim and Perpetrator of Drug-Drug Interactions via CYP3A Metabolism and Transporters. Clinical and translational science (2023)
Aline Barth, Caroline R Perry, Shaila Shabbir, Maciej J Zamek-Gliszczynski, Sebin Thomas, Etienne F Dumont, Darin B Brimhall, Dung Nguyen, Meenakshi Srinivasan, Brandon Swift
Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug-drug interactions via CYP3A metabolism and transporters. Clinical and translational science (2023)
Courtney Tiffany, Etienne F Dumont, Mohammad Hossain, Meenakshi Srinivasan, Brandon Swift
Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects. Clinical and translational science 15 (9) (2022)
Meenakshi Srinivasan, Annesha White, Jason Lott, Todd Williamson, Sheldon X Kong, Leo Plouffe
Quantifying the economic burden of unintended pregnancies due to drug-drug interactions with hormonal contraceptives from the United States payer perspective. Gates open research 5 (2021)
Meenakshi Srinivasan, Annesha White, Jason Lott, Todd Williamson, Sheldon X Kong, Leo Plouffe
Quantifying the economic burden of unintended pregnancies due to drug-drug interactions with hormonal contraceptives from the United States payer perspective. Gates open research 5 (2021)